Ahmed Kotb, Hematologist and Bone marrow transplanter at King Faisal Specialist Hospital International Holding Company, shared a post on X:
“Bispecific Antibodies vs. CAR-T for Relapsed/Refractory Follicular Lymphoma
BsAb
Off-the-shelf, outpatient, low toxicity
Possible indefinite treatment
CAR-T
Very high CR, long PFS, curative potential
Neurotoxicity risk,long wait time.”
